Publications by authors named "James Napier"

Claim this Profile
D
Discovery and Development of Metal-Catalyzed Coupling Reactions in the Synthesis of Dasabuvir, an HCV-Polymerase Inhibitor.
David M Barnes, Shashank Shekhar, Travis B Dunn, Jufang H Barkalow, Vincent S Chan, James J Napier

J Org Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin poisoning treated with high dose insulin dextrose therapy: a case series.
Theodore Young, Joaquim Cevallos, James Napier, Juan Martin-Lazaro

Acta Med Litu· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the Subclonal Evolution of Cancer Cell Populations.
Diego Chowell, James Napier, Rohan Gupta, Karen S Anderson, Carlo C Maley

Cancer Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infrarenal aortic aneurysm: an incidental radiological finding.
Daniel Glassman, Marina Yiasemidou, James Napier, Malayanil Bhattacharyya

J Emerg Med· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of the synthetic process to prepare the tripeptide segment of ABT-510.
Calvin L Becker, Jean Christophe Califano, John C Tolle, James J Napier, Lawrence Kolaczkowski

Adv Exp Med Biol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impurity rejection in the crystallization of ABT-510 as a method to establish starting material specifications.
John C Tolle, Calvin L Becker, Jean C Califano, Jane L Chang, Kevin Gernhardt, James J Napier

Adv Exp Med Biol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constrained 7-fluorocarboxychromone-4-aminopiperidine based Melanin-concentrating hormone receptor 1 antagonists: the effects of chirality on substituted indan-1-ylamines.
Andrew J Souers, Rajesh R Iyengar, Andrew S Judd, David W A Beno, Ju Gao, James J Napier

Bioorg Med Chem Lett· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of chromone-2-carboxamide melanin concentrating hormone receptor 1 antagonists: assessment of potency, efficacy, and cardiovascular safety.
John K Lynch, Jennifer C Freeman, Andrew S Judd, Rajesh Iyengar, Mathew Mulhern, James J Napier

J Med Chem· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for cardiovascular safety: a structure-activity approach for guiding lead selection of melanin concentrating hormone receptor 1 antagonists.
Philip R Kym, Andrew J Souers, Thomas J Campbell, John K Lynch, Andrew S Judd, James J Napier

J Med Chem· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.
Andrew J Souers, Ju Gao, Dariusz Wodka, Andrew S Judd, Mathew M Mulhern, James J Napier

Bioorg Med Chem Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis